Background/Aims: The present study was conducted to understand biochemical and biological characteristics of the phosphatidylinositol (PI) 
DCP-LA-Phosphatidylinositol and Its Enantiomer Exhibit Different Bioactivities

Introduction
The phospholipid phosphatidylinositol (PI) is a member of plasma membrane components and plays a critical role in cell proliferation, differentiation, migration, chemotaxis, phagocytosis, and survival [1] . Furthermore, emerging evidence has pointed to the implication of PI in the control of vesicular trafficking, membrane dynamics, actin cytoskeleton organization, activation of ion channels, and transporters [2, 3] . Phosphatidylinositol 4,5-biphosphate (PIP 2 ) is hydrolyzed into diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ) by phospholipase C [4, 5] . IP 3 releases Ca 2+ through IP 3 -gated calcium channel on the endoplasmic reticulum, an intracellular calcium store, and classical PKCs PKCα, -βΙ, -βΙΙ, and -γ are activated by intracellularly released Ca 2+ and diacylglycerol [4, 5] . PIP 2 , on the other hand, serves as a substrate for phosphatidylinositol 3-kinase (PI3K) to produce phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ). PIP 3 recruits and activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which in turn, activates Akt followed by Rac1/Cdc42. PI, thus, is linked to diverse signaling cascades.
To understand the bioactivities of PI by itself, but not metabolites, we have newly synthesized the PI derivative 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidyl-D-1-inositol (diDCP-LA-PI) and its enantiomer 1,2-Obis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidyl-L-1-inositol (diDCP-LA-PIe), with 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) on the α and β position (Fig. 1) , which would not be easily degraded in cells. We have earlier found that the linoleic acid derivative DCP-LA selectively and directly activates protein kinase Cε (PKCε) [6, 7] or indirectly activates Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) by inhibiting protein phosphatase 1 (PP1) [8] .
In the present study, we examined the effects of diDCP-LA-PI, diDCP-LA-PIe, the natural types of PIs 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol)(DOPI) and 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-myo-inositol)(DPPI) (Fig. 1) on activities of PKC, protein phosphatases such as PP1, PP2A, and protein tyrosine phosphatase 1B (PTP1B) and Akt1/2. We show here that PIs by themselves, but not metabolites, serve as an intracellular signaling cascade and that diDCP-LA-PI and diDCP-LA-PIe exhibit different bioactivities with different potentials.
Materials and Methods
NMR analysis
1 H-NMR spectra were recorded on a JEOL JNM-ECX400 spectrometer, operating at 400 MHz. Chemical shifts were reported downfield from TMS (δ = 0.00) or CHCl 3 (δ = 7.26) for 1 H-NMR. ESI-MS spectra were taken on Bruker micrOTOF-Q mass spectrometer. Column chromatography was performed with silica gel 60 (40-50 µm and 40-100 µm) purchased from KANTO CHEMICAL Co. (Tokyo, Japan). All reaction were monitored by thin-layer chromatography carried out on a 0.25 mm silica gel plates 60 F254 (Merck, Darmstadt, Germany) using UV light, iodine, m-bromo cresol green, or 5 % (w/v) ethanolic phosphomolybdic acid solution and heat as developing agents.
Synthesis of (R)-3-benzyloxy-1,2-propanediol
To a solution of (S)-(+)-2,2-dimethyl-1,3-dioxolane-4-methanol (1.0 g, 7.6 mmol) in dimethylformamide (10 ml) were added 60% NaH (0.61 g, 15.1 mmol) and benzyl bromide (1.1 ml, 9.1 mmol) under ice-cooling. After stirring for 15 min at room temperature, water was added to the reaction mixture. The aqueous layer was extracted with hexane, and the organic layer was washed with H 2 O and brine. Then it was dried over anhydrous MgSO 4 , and concentrated under reduced pressure to give 4-benzyloxymethyl-2,2-dimethyl-1,3-dioxolane, which was used without further purification.
To a solution of 4-benzyloxymethyl-2,2-dimethyl-1,3-dioxolane in methanol (17.4 ml) was added concentrated HCl (1.93 ml) under ice-cooling. After stirring for 30 min at 60 °C, a saturated aqueous solution of NaHCO 3 was added to the reaction mixture under ice-cooling. The aqueous layer was washed with hexane, 
Synthesis of 3-O-benzyl-1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycerol
Synthesis of 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycerol
57 mmol) and 10% (w/v) palladium on activated carbon (480 mg) in ethanol (80 ml) was stirred under hydrogen (1 atm) for 15 min at room temperature. The catalyst was removed through a pad of Celite, rinsed with ethyl acetate. The combined organic layers were concentrated under reduced pressure to give 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycerol (1.05 g, 100%) as oil. 
phosphate in ethanol (3 ml) was added 10% (w/v) palladium on activated carbon (21 mg). The resulting suspension was placed under hydrogen (1 atm) and stirred for 2 h at room temperature. The catalyst was removed through a pad of Celite, rinsed with ethyl acetate, and concentrated under reduced pressure. The resulting crude product was purified by a silica gel column chromatography (chloroform:methanol = 10:1) to give 1,2-O-bis-[8-{2-(2-pentylcyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidyl-D-1-inositol (10 mg, 55%) as a white solid. 39 mmol) and 1H-tetrazole (0.073 g, 1.04 mmol) were added, and 70% (v/v) aqueous solution of tert-butyl peroxide (0.34 ml, 2.6 mmol) was added to the reaction mixture and stirred for 20 min at the same temperature. After adding 10% (w/v) aqueous solution of Na 2 S 2 O 3 , the aqueous layer was extracted with CH 2 Cl 2 . The combined organic layer was dried over anhydrous MgSO 4 and concentrated under reduced pressure. The crude product was purified by a silica gel column chromatography (toluene:ethyl acetate = 6: 
-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-3-glyceryl) O-methyl O-(2',3',4',5',6'-penta-O-benzyl-L-1-inositol)
phosphate (90 mg, 0.070 mmol) in 2-butanone (2 ml). After stirring for 3 h at 80 °C, 2 N HCl was added to the reaction mixture. The aqueous layer was extracted with chloroform. The organic layer was washed with H 2 O and brine, and the combined organic layer was dried over anhydrous MgSO 4 
and concentrated under reduced pressure to give O-(1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-3-glyceryl) O-(2',3',4',5',6'-penta-O-benzyl-L-1-inositol) phosphate.
To
a solution of O-(1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-3-glyceryl) O-(2',3',4',5',6'-penta-O-benzyl-L-1-inositol)
phosphate in ethanol (5 ml) was added 10% (w/v) palladium on activated carbon (70 mg). The resulting suspension was stirred under hydrogen (1 atm) for 2 h at room temperature. The catalyst was removed through a pad of Celite, rinsed with ethyl acetate, Cell culture PC-12 cells, obtained from RIKEN Cell Bank (Tsukuba, Japan), were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% (v/v) heat-inactivated fetal bovine serum (FBS) and 10% (v/v) heatinactivated horse serum, supplemented with penicillin (100 U/ml), and streptomycin (0.1 mg/ml), in a humidified atmosphere of 5% CO 2 and 95% air at 37 °C.
Cell-free PKC assay PKC activity in the cell-free systems was quantified by the method previously described [6] . Briefly, synthetic PKC substrate peptide (10 µM) was reacted with a variety of PKC isozymes in a medium containing 20 mM Tris-HCl (pH 7.5), 5 mM Mg-acetate, and 10 µM ATP without phosphatidylserine and diacylglycerol in the presence and absence of diDCP-LA-PI, diDCP-LA-PIe, DOPI, or DPPI at 30 °C for 5 min. Activity for novel PKCs such as PKC-δ and -ε was assayed in Ca 2+ -free medium and activity for the other PKC isozymes in the medium containing 100 µM CaCl 2 . After loading on a reversed phase HPLC (LC-10ATvp, Shimadzu Co., Kyoto, Japan), a substrate peptide peak and a new product peak were detected at an absorbance of 214 nm. Areas for non-phosphorylated and phosphorylated PKC substrate peptide were measured (total area corresponds to concentration of PKC substrate peptide used here), and the amount of phosphorylated substrate peptide was calculated. Phosphorylated substrate peptide (pmol/1 min) was used as an index of PKC activity.
In situ PKC assay PKC activity in PC-12 cells was assayed by the method previously described [6] . Cells were treated with diDCP-LA-PI or diDCP-LA-PIe in the presence and absence of GF109203X at 37 °C for 10 min in an extracellular solution (137 mM NaCl, 5.4 mM KCl, 10 mM MgCl 2 , 5 mM EGTA, 0.3 mM Na 2 HPO 4 , 0.4 mM K 2 HPO 4 , and 20 mM HEPES, pH 7.2). Then, cells were rinsed with 100 µl of Ca
2+
-free phosphate-buffered saline and incubated at 30 °C for 15 min in 50 µl of the extracellular solution containing 50 µg/ml digitonin, 25 mM glycerol 2-phosphate, 200 µM ATP, and 100 µM synthetic PKC substrate peptide. The supernatants were collected and boiled at 100 °C for 5 min to terminate the reaction. Aliquot of the solution (20 µl) was loaded onto a reversed phase HPLC (LC-10ATvp). A substrate peptide peak and a new product peak were detected at an absorbance of 214 nm. Areas for non-phosphorylated and phosphorylated substrate peptide were measured (total area corresponds to concentration of substrate peptide used here), and the amount of phosphorylated substrate peptide was calculated. Phosphorylated substrate peptide (pmol/min/cell protein weight) was used as an index of PKC activity.
Assay of PP1, PP2A, and PTP1B activities Activities of protein phosphatases under the cell-free conditions were assayed by the method previously described [9] . The human recombinant PP1 was purchased from New England BioLabs Inc. (Ipswich, MA, USA) and the human recombinant PP2A from Wako Pure Chemical Industries (Osaka, Japan). The human PTP1B was cloned into pGEX-6P-3 vector with a GST tag at the NH 2 terminus, and expressed in competent E. coli BL21 (DE3), suitable for transformation and protein expression. GST-fusion PTP1B was affinity-purified using Glutathione Sepharose 4B (GE Healthcare Bio-Science KK, Tokyo, Japan). Each phosphatase activity was assayed by reacting with p-nitrophenyl phosphate (pNPP)(Sigma, St. Louis, MO, USA) as a substrate. Enzyme was preincubated at 30 °C (for PP1) or 37 °C (for PP2A and PTP1B) for 30 min in a reaction medium [50 mM HEPES, 100 mM NaCl, 2 mM dithiothreitol, 0.01% (v/v) Brij-35, 1 mM MnCl 2 , pH 7.5 for PP1; 50 mM Tris-HCl, 0.1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, pH 7.0 for PP2A; and 50 mM HEPES, 1 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol, pH 7.2 for PTP1B] in the presence and absence of phosphatase inhibitors, diDCP-LA-PI, diDCP-LA-PIe, DOPI, or DPPI. Then, pNPP at a concentration of 5 mM for PP1, 500 µM for PP2A, and 10 mM for PTP1B was added to the reaction medium followed by 60-min Fig. 2 . Effect of PIs on PKC activity. In the cell-free systems, PKC activity was monitored. PKC isozymes as indicated were assayed in the absence and presence of diDCP-LA-PI (100 µM)(A), diDCP-LA-PIe (100 µM) (B), DOPI (100 µM)(C), and DPPI (100 µM)(D). In the graphs, each value represents the mean (± SEM) PKC activity (pmol/min) (n=4 independent experiments). P values as compared with each PKC isozyme activity in the absence of PIs, unpaired t-test. NS, not significant. Fig. 3 . Effects of diDCP-LA-PI or diDCP-LA-PIe on PKC activity in PC-12 cells. Cells were untreated and treated with diDCP-LA-PI (A) or diDCP-LA-PIe (B) at concentrations as indicated in the presence and absence of GF109203X (GF)(100 nM). Phosphorylated substrate peptide (pmol/min/µg cell protein) was used as an index of PKC activity. In the graphs, each column represents the mean (± SEM) PKC activity (n=4 independent experiments). P value, Dunnett's test. (1 µM) for the periods of time as indicated in the absence (-) and presence of okadaic acid (Okadaic A)(100 nM) followed by Western blotting using antibodies against pT308/309, pS473/474, and Akt1/2. The signal intensity for pT308 and pS473 was normalized by that for total Akt1/2. In the graphs, each column represents the mean (± SEM) normalized intensity for pT308/309 and pS473/474 (n=4 independent experiments). P values, Dunnett's test.
